	Quarter Ended
(In millions, except per share data)	September 30 (1)		December 31 (2)		March 31 (3)		June 30 (4)		Total Year

Fiscal 2018
Net Sales	$	3,274	$	3,744	$	3,370	$	3,295	$	13,683
Gross Profit	2,563		2,991		2,687		2,598		10,839
Operating Income	568		710		497		277		2,052
Net Earnings Attributable to The Estée Lauder Companies Inc.	427		123		372		186		1,108

Net earnings attributable to The Estée Lauder Companies Inc. per common share:
Basic	1.16		.33		1.01		.51		3.01
Diluted	1.14		.33		.99		.49		2.95

Fiscal 2017
Net Sales	$	2,865	$	3,208	$	2,857	$	2,894	$	11,824
Gross Profit	2,269		2,571		2,266		2,281		9,387
Operating Income	418		617		427		230		1,692
Net Earnings Attributable to The Estée Lauder Companies Inc.	294		428		298		229		1,249

Net earnings attributable to The Estée Lauder Companies Inc. per common share:
Basic	.80		1.17		.81		.62		3.40
Diluted	.79		1.15		.80		.61		3.35

⁽¹⁾

Fiscal 2018 first quarter results include charges associated with restructuring and other activities of $(38) million ($(26) million after tax, or $(.07) per diluted common share). Fiscal 2017 first quarter results include charges associated with restructuring and other activities of $(31) million ($(20) million after tax, or $(.05) per diluted common share) and the changes in fair value of contingent consideration of $(4) million ($(3) million after tax, or $(.01) per diluted common share).

⁽²⁾

Fiscal 2018 second quarter results include charges associated with restructuring and other activities of $(69) million ($(55) million after tax, or $(.15) per diluted common share). The fiscal 2018 second quarter results also include charges resulting from the TCJA totaling $(394) million, or $(1.05) per diluted common share, relating to the Transition Tax, the remeasurement of U.S. net deferred tax assets and the net deferred tax liability related to foreign withholding taxes on certain foreign earnings. Fiscal 2017 second quarter results include charges associated with restructuring and other activities of $(41) million ($(26) million after tax, or $(.07) per diluted common share).

⁽³⁾

Fiscal 2018 third quarter results include charges associated with restructuring and other activities of $(100) million ($(75) million after tax, or $(.20) per diluted common share) and the changes in fair value of contingent consideration of $9 million ($6 million after tax, or $.02 per diluted common share). The fiscal 2018 third quarter results also include a net credit resulting from the TCJA of $2 million, which did not have an impact to diluted earnings per share, relating to the Transition Tax and the remeasurement of U.S. net deferred tax assets. Fiscal 2017 third quarter results include charges associated with restructuring and other activities of $(62) million ($(42) million after tax, or $(.11) per diluted common share) and the changes in fair value of contingent consideration of $3 million ($5 million after tax, or $.01 per diluted common share).

⁽⁴⁾

Fiscal 2018 fourth quarter results include charges associated with restructuring and other activities of $(50) million ($(37) million after tax, or $(.10) per diluted common share) and the changes in fair value of contingent consideration of $37 million ($29 million after tax, or $.08 per diluted common share). The fiscal 2018 fourth quarter results reflect impacts and charges resulting from the TCJA totaling $(58) million, or $(.16) per diluted common share, including the Transition Tax, the remeasurement of U.S. net deferred tax assets and the net deferred tax liability related to foreign withholding taxes on certain foreign earnings. Fiscal 2017 fourth quarter results include charges associated with restructuring and other activities of $(78) million ($(55) million after tax, or $(.15) per diluted common share), the changes in fair value of contingent consideration of $58 million ($42 million after tax, or $.11 per diluted common share), goodwill and other intangible asset impairments of $(31) million ($(23) million after tax, or $(.06) per diluted common share) and the China deferred tax asset valuation allowance reversal of $75 million, or $.20 per diluted common share.